Product availability varies by country. Consult your bioMérieux representative.
©2023 bioMérieux, Inc. • BIOMÉRIEUX, the BIOMÉRIEUX logo, PIONEERING DIAGNOSTICS, BIOFIRE, FILMARRAY, FIREWORKS, and SPOTFIRE are used pending and/or registered trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies • Patents • 515 Colorow Drive, Salt Lake City, UT 84108 • Tel: (800) 634-7656
bioMérieux S.A. • 69280 Marcy l’Etoile • France • www.biomerieux-usa.com
Solutions for CLIA-moderate settings.
I want to discover how BIOFIRE syndromic testing can impact my practice and patients
Fill out the form below to have a representative reach out to you.
By checking the box, you have read and agree to the Privacy Policy and agree to receive emails from bioMérieux on new products, newsletters, surveys or upcoming events. You can unsubscribe at any time.
Product Theater
This Changes Everything—Introducing the
faster, smaller, and smarter
BIOFIRE® SPOTFIRE® System*.
*Investigational use only. Currently under FDA review. Not available for sale.
Date: Thursday, September 22, 2022
Where: Theater 6
BIOFIRE® FILMARRAY® Gastrointesintal (GI) Panel*:
Identify 22 of the most common pathogens associated with infectious gastroenteritis, including bacteria, viruses, and parasites, with results available in about an hour.
11:30 - 12:15 pm
BIOFIRE® FIREWORKSTM:
This centralized data management web portal gives users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, and workflow management.
BIOFIRE® Syndromic Trends (TREND):
Access pathogen trends for your facility, as well as regional and national pathogen trends. Get automatic weekly email reports and explore your data using BIOFIRE TREND’s online dashboard. For use with the BIOFIRE® FILMARRAY® TORCH and BIOFIRE® FILMARRAY® 2.0 systems.
Insights at Your Fingertips.
Visit booth #1303 to see the faster, smaller, and smarter BIOFIRE® SPOTFIRE® System.*
Solutions for CLIA-waived settings.
The SPOTFIRE Respiratory Solution brings the power of PCR testing to point-of-care settings. Identify the most probable respiratory pathogens, including influenza, rhinovirus, respiratory syncytial virus, and SARS-CoV-2—all in one easy-to-use test, with results in about 15 minutes.
BIOFIRE® SPOTFIRE® Respiratory Solution
BIOFIRE® SPOTFIRE® Respiratory (R) Panel
1 PCR test. 15 targets. ~15 minutes.
BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
1 PCR test. 5 targets. ~15 minutes.
Based on patient symptoms and sample type, users can choose to run either a Respiratory test (15 targets) or a Sore Throat test (15 targets).
±Under FDA review. Seeking CLIA waiver. Subject to change. Not available for sale in the United States.
Product availability varies by country. Consult your bioMérieux representative.
